logo-loader
viewHaydale Graphene Inds PLC

Haydale Graphene signs deal with IRPC for medical products, including face masks

The pair will develop organic conducting-based printing smart fabric for medical use using Haydale’s technology

Haydale Graphene Inds PLC - Haydale Graphene Industries PLC signs with IRPC for medical products, including face masks

Haydale Graphene Industries PLC (LON:HAYD) climbed on Wednesday on the back of a new collaboration with IRPC to develop organic conducting-based printing smart fabric for medical use, including face masks, using Haydale’s technology.

The AIM-listed firm said it has been developing a functionalised graphene-coated fabric during the coronavirus (COVID-19) pandemic, and tests carried out by the Thailand Textile Institute showed antibacterial finishes over 99.3% on the textile material after ten washes.

READ: Haydale Graphene Industries advances to phase 2 with its IRPC collaboration

The advanced materials group noted that the agreement with IRPC includes the development of a new washable functionalised graphene-enhanced fabric mask, while the scope of the project will be to focus on the commercial production of fabric, though further development will take place to assess additional fabric properties such as Virus Filtration Efficiency (VFE), UV Protection and EMC protection.

The global healthcare personal protective equipment (PPE) industry is worth US$17bn-19bn, Haydale added, with huge growth seen in the personal healthcare industry, where the graphene-coated fabric taps in.

Haydale’s bespoke ink will be delivered on an exclusive basis for commercial applications and the companies believe the new fabric will be commercially available this year.

“Working with IRPC we are able to quickly react to a current industry requirement,” Haydale chief executive Keith Broadbent said in a statement.

“It is great to see that these products are benefiting from our core functionalisation process; particularly the antibacterial nature of the inks and the part they can play in the production of healthcare PPE. With the global PPE requirements continuing to grow, we anticipate this project to be very well received and look forward to seeing this progress to commercialisation."

Shares climbed 28% to 2.6p early on Wednesday.

--Adds shares--

Quick facts: Haydale Graphene Inds PLC

Price: 4.46 GBX

LSE:HAYD
Market: LSE
Market Cap: £15.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amryt Pharma releases Q-2 financials that show strong revenue growth as...

Amryt Pharma (Nasdaq: AMYT) CEO Dr Joe Wiley joined Steve Darling from Proactive with news the company saw a nice increase in revenue as they released their Q-2 numbers. Dr Wiley talked about some of the numbers and what was driving that revenue. Wiley also told Proactive the company has, for...

32 minutes ago

2 min read